Skip to content

Safety of Sports for Patients With Implantable Cardioverter-Defibrillators

Safety of Sports for Patients With Implantable Cardioverter-Defibrillators: A Multi-Center Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00637754
Enrollment
400
Registered
2008-03-18
Start date
2006-09-30
Completion date
2015-01-31
Last updated
2015-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Arrhythmias

Keywords

ICD, Sports

Brief summary

The registry will obtain information to determine the safety of sports participation for patients with defibrillators (ICDs).

Detailed description

Patients who are participating in sports who have defibrillators will be invited to participate in a prospective registry to determine the rate of adverse events occurring during sporting activities. Patients will be followed for four years and adverse events quantified. Yale is the coordinating center for this multicenter registry.

Interventions

None listed

Sponsors

Medtronic
CollaboratorINDUSTRY
Abbott Medical Devices
CollaboratorINDUSTRY
Boston Scientific Corporation
CollaboratorINDUSTRY
Yale University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* individuals between the ages of 10 and 60 * has a defibrillator * plays a competitive/organized sport more vigorous than golf or bowling or participates in a dangerous sport

Exclusion criteria

* children under 10 years (as they engage in primarily recreational sports) * individuals over the age of 60 years (maintain a homogenous population) * inability to give informed consent

Design outcomes

Primary

MeasureTime frame
Resuscitated arrest or death during sports, or injury during sports due to arrhythmic symptoms and/or shock.four years

Secondary

MeasureTime frame
System malfunction and incidence of ventricular arrhythmias (VA) requiring multiple shocks for terminationfour years.

Countries

Australia, Belgium, Canada, Czechia, France, Germany, Israel, Netherlands, Norway, Poland, Spain, Switzerland, United Kingdom, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026